Portfolio company
Lykos
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
Lykos Therapeutics develops psychedelic-assisted therapies, specifically midomafetamine capsules combined with psychological intervention, to treat patients with post-traumatic stress disorder.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Transcend Therapeutics
This clinical-stage biotechnology company develops rapid-acting psychoactive medicines to treat patients suffering from neuropsychiatric diseases, including post-traumatic stress disorder and depression.
Mycrodose Therapeutics
This pharmaceutical company develops advanced drug delivery systems for psychedelic and cannabinoid compounds to treat mental health and cognitive degenerative diseases.
Psyon
This company provides psychedelic-assisted psychotherapy and psychiatric care to patients seeking treatment for mental health disorders.
Mindstate
This pharmaceutical company develops designer psychedelic compounds using artificial intelligence to treat mental health conditions such as treatment-resistant post-traumatic stress disorder.
Sunstone Therapies
The company provides psychedelic-assisted therapy and clinical trials for patients with cancer and complex mental health conditions.
Mindstate Design Labs
This biotechnology company develops custom psychedelic therapeutics using an artificial intelligence platform to treat mental health conditions for patients with various psychiatric disorders.
Delix Therapeutics
This biotechnology company develops non-hallucinogenic neuroplasticity-promoting medicines to treat patients with neuropsychiatric and neurodegenerative conditions.
Helus Pharma
This pharmaceutical company develops serotonergic agonists and psychedelic medicines to treat patients with depression, anxiety and other mental health conditions.
